Increased propensity for calcium phosphate kidney stones with topiramate use

Author： Vega Damaris Maalouf Naim M Sakhaee Khashayar

ISSN： 1474-0338

Source： Expert Opinion on Drug Safety, Vol.6, Iss.5, 2007-09, pp. : 547-557

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Optimal use of phosphate binders in chronic kidney disease

By Sonikian Makrouhi Papachristou Evangelos Goumenos Dimitrios S

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 18, 2013-12 ,pp. : 2521-2532

Informa Healthcare

Access to resources Recommend Favorite

Hypersensitivity to Topiramate Sprinkle Capsules Does not Preclude the Use of Topiramate Tablets

By Marsden D.

Pediatric Drugs, Vol. 6, Iss. 2, 2004-01 ,pp. : 133-135

Adis International

Access to resources Recommend Favorite

Lanthanum carbonate: a guide to its use as a phosphate-binding agent in patients with chronic kidney disease

Drugs & Therapy Perspectives, Vol. 26, Iss. 8, 2010-08 ,pp. : 1-4

Adis International

Access to resources Recommend Favorite

Use of Gastrointestinal Proton Pump Inhibitors to Regulate Osteoclast- Mediated Resorption of Calcium Phosphate Cements In Vivo

Current Drug Delivery, Vol. 6, Iss. 2, 2009-04 ,pp. : 192-198

Bentham Science Publishers

Access to resources Recommend Favorite

Topiramate: A Review of its Use in the Treatment of Epilepsy

By Lyseng-Williamson Katherine A. Yang Lily P.H.

Drugs, Vol. 67, Iss. 15, 2007-01 ,pp. : 2231-2256

Adis International

Access to resources Recommend Favorite